David Lavie
Impact in
-
- Phytochemicals and Medicinal Plants
- Medicinal Plants and Neuroprotection
- Toxicology top 1%
Papers in
-
- Phytochemicals and Medicinal Plants 36
- Genetics 33
- Myeloproliferative Neoplasms: Diagnosis and Treatment 23
- Advances in Cucurbitaceae Research 23
David Lavie
225 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 131
- Complementary and alternative medicine 1.2k
- Toxicology 160
- Genetics 476
- Hematology 394
- Plant Science 1.0k
Countries citing papers authored by David Lavie
This map shows the geographic impact of David Lavie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lavie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lavie more than expected).
Fields of papers citing papers by David Lavie
This network shows the impact of papers produced by David Lavie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lavie. The network helps show where David Lavie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Lavie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 25 | |
| 14 | 2023 | 3 | |
| 15 | 2021 | 2 | |
| 16 | 2018 | 16 | |
| 17 | 2015 | 7 | |
| 18 | 1995 | 153 | |
| 19 | 1992 | 59 | |
| 20 | Immunosuppressive activity of two plant steroidal lactones withaferin A and withanolide E. | 1978 | 39 |
About David Lavie
David Lavie is a scholar working on Complementary and alternative medicine, Genetics, Hematology, Pathology and Forensic Medicine and Oncology, having authored 230 papers that have together received 4.4k indexed citations. Recurring topics across this work include Phytochemicals and Medicinal Plants (36 papers), Lymphoma Diagnosis and Treatment (35 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Advances in Cucurbitaceae Research (23 papers), Chronic Myeloid Leukemia Treatments (22 papers), Natural product bioactivities and synthesis (21 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Phytochemical compounds biological activities (14 papers). The work is most often cited by research in Complementary and alternative medicine (1.2k citations), Toxicology (160 citations), Genetics (476 citations), Hematology (394 citations) and Plant Science (1.0k citations). David Lavie has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Erwin Glotter, Daniel Meruelo, G. Lavie, I. Kirson, Youval Shvo, A. Abraham, E.C. Levy, Gad Lavie, Yehuda Mazur and Mahendra Kumar Jain. Their work appears in journals such as Blood, Tetrahedron, Phytochemistry, Journal of the American Chemical Society and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.